Development

Feliza Mirasol is the science editor for 

Videos

Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics at AAPS PharmSci 360.

The Need for LBFs and Challenges in Oral Biologic Formulation (AAPS PharmSci 360)

Articles

Solving the challenge of better-stabilized temperature-sensitive biomolecules hinges on innovative formulation strategies.

Prioritizing Formulation Strategies for Temperature-Sensitive Biotherapeutics

At this year's CPHI Milan, Camille Dumont, PhD, manager, customer applications, Lonza, discussed current industry trends that are impacting oral solid dose formulation work.

A Discussion on Industry Trends and Their Influence on Oral Solid Dose Formulations (CPHI Milan 2024)

Podcasts

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Vectura’s expertise in the field includes formulation and device development for dry powder inhalers and pressurized metered dose inhalers, among other products and services.

Phillips Medisize Expands Inhalation Drug Delivery Capabilities with Acquisition of Vectura

Alternative delivery methods for biologics continues to be explored that offer less invasive, less painful administration.

Exploring Innovative Means for Biologics Delivery

AAV and lentivirus both have pros and cons in their use for specific gene therapy applications.

Comparing Viral Vectors for Gene Therapy Delivery

 is Industry Market Manager Biopharma, Pharma EMEA - Brenntag GmbH.

Biopharmaceutical production faces the challenge of ensuring the quality of raw materials due to a lack of specific guidelines. By implementing effective risk assessment strategies and working with reliable, selected solution providers, biopharmaceutical manufacturers can minimize these challenges and improve product quality.

The Quest for Quality: Challenges and Strategies in Raw Material Selection for Biopharmaceuticals

Editor of Pharmaceutical Technology Europe

In the premiere episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, vice president, Technical at Parexel, discuss the challenges involved in changing an excipient supplier. 

Quality Considerations in Changing Excipient Providers

Joe Petroziello is Executive Vice President, Head of Global Medical Affairs & Corporate Development at MJH Life Sciences.

At BIO 2024 in San Diego, John Dunlop, PhD, chief scientific officer at Aliada Therapeutics, sat down for an interview with BioPharm International to discuss the firm’s MODEL platform and its potential impact on therapeutic delivery for brain-related conditions. 